Announcements Trials
Browse Landscape

Phase

Phase 2 20Phase 3 6Phase 1 6Phase NA 5Phase EARLY_PHASE1 4Phase 1/2 4

Status

Completed 5Unknown 4Active not recruiting 4Terminated 2Recruiting 2Withdrawn 1

Sponsor Class

OTHER 4

Study Type

Interventional 4

Sponsor

Cancer Type

NET 4Endocrine 4

Conditions

Prostatic Neoplasms 10Glioma 9Glioblastoma 8Sarcoma 7Pancreatic Neoplasms 6Neoplasms 6Neoplasm Metastasis 6Brain Neoplasms 5Recurrence 4Neuroendocrine Tumors 4Neuroblastoma 4Lymphoma 4Lung Neoplasms 4Head and Neck Neoplasms 4Colonic Neoplasms 4Triple Negative Breast Neoplasms 3Squamous Cell Carcinoma of Head and Neck 3Multiple Myeloma 3Melanoma 3Fallopian Tube Neoplasms 3Colorectal Neoplasms 3Carcinoma, Renal Cell 3Breast Neoplasms 3Uterine Cervical Neoplasms 2Urinary Bladder Neoplasms 2Smoldering Multiple Myeloma 2Smoking Cessation 2Smoking 2Skin Neoplasms 2Sarcoma, Alveolar Soft Part 2

Interventions

lutetium Lu 177 dotatate 190Y-octreotide, DOTA-Tyr(3)- 168Ga-pentixafor 13-Iodobenzylguanidine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Phase EARLY_PHASE1 × Active not recruiting × Neuroendocrine Tumors × Clear all
NCT04544098 2026-05-07

Lutathera in People With Gastroenteropancreatic (GEP), Bronchial or Unknown Primary Neuroendocrine Tumors That Have Spread to the Liver

Memorial Sloan Kettering Cancer Center

Phase EARLY_PHASE1 Active not recruiting
10 enrolled
EndocrineNET

Neuroendocrine Tumors

NCT06148636 2025-11-04

A Safety Study of 212Pb-VMT-alpha-NET in Patients With Neuroendocrine Tumors

University of Iowa

Phase EARLY_PHASE1 Active not recruiting
24 enrolled
EndocrineNET

Adenoma, Islet Cell, Recurrence, Neuroendocrine Tumors

NCT03335670 2025-07-14

Gallium 68 Pentixafor in Patients With Neuroendocrine Tumors

University of Iowa

Phase EARLY_PHASE1 Active not recruiting
30 enrolled
EndocrineNET

Neuroendocrine Tumors

NCT03044977 2023-08-16

Study to Evaluate the Safety of Combining Two Radionuclide Therapies to Treat Mid-gut Neuroendocrine Tumors

University of Iowa

Phase EARLY_PHASE1 Active not recruiting
20 enrolled
EndocrineNET

Neuroendocrine Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡